Sale!

NCF1 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome B Positive Type 1 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The NCF1 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome B Positive Type 1 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the NCF1 gene responsible for chronic granulomatous disease (CGD). This comprehensive genetic analysis utilizes next-generation sequencing technology to detect autosomal recessive inheritance patterns associated with cytochrome b-positive type 1 CGD. The test provides crucial information for patients experiencing recurrent infections, granuloma formation, and immune system deficiencies. Early detection through this $500 USD test enables proactive management and targeted treatment strategies. Results are typically available within 3-4 weeks from blood or DNA samples. Genetic counseling is recommended before testing to understand family implications and inheritance patterns.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

NCF1 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome B Positive Type 1 NGS Genetic DNA Test

Comprehensive Genetic Testing for Chronic Granulomatous Disease

The NCF1 Gene Granulomatous Disease DNA Test represents a breakthrough in genetic diagnostics for individuals at risk of chronic granulomatous disease (CGD). This sophisticated Next Generation Sequencing (NGS) analysis specifically targets mutations in the NCF1 gene, which plays a critical role in the proper functioning of the immune system’s phagocytic cells. Chronic granulomatous disease is a rare inherited immunodeficiency disorder characterized by the immune system’s inability to effectively combat certain bacterial and fungal infections.

What This Advanced Genetic Test Measures

Our comprehensive NGS genetic DNA test precisely identifies:

  • Mutations in the NCF1 gene responsible for cytochrome b-positive type 1 CGD
  • Autosomal recessive inheritance patterns affecting neutrophil function
  • Specific genetic variants that impair NADPH oxidase complex formation
  • Pathogenic changes affecting the p47phox protein production
  • Genetic markers associated with increased infection susceptibility

Who Should Consider This Genetic Test?

This specialized genetic analysis is recommended for individuals experiencing:

  • Recurrent bacterial and fungal infections despite treatment
  • Unexplained granuloma formation in various organs
  • Family history of chronic granulomatous disease
  • Persistent lymphadenopathy or hepatosplenomegaly
  • Delayed wound healing with excessive inflammation
  • Autoimmune manifestations alongside infection susceptibility
  • Abnormal dihydrorhodamine (DHR) flow cytometry results

Significant Benefits of Early Genetic Detection

Undergoing the NCF1 Gene Granulomatous Disease DNA Test provides numerous advantages:

  • Early and accurate diagnosis enabling targeted treatment strategies
  • Comprehensive genetic counseling for family planning decisions
  • Personalized infection prevention and management protocols
  • Improved quality of life through proactive medical interventions
  • Potential eligibility for advanced therapies and clinical trials
  • Reduced healthcare costs through preventive care measures
  • Peace of mind through definitive genetic confirmation

Understanding Your Genetic Test Results

Our genetic specialists provide comprehensive interpretation of your results:

  • Positive Result: Indicates presence of NCF1 gene mutations confirming CGD diagnosis, requiring immediate consultation with immunology specialists
  • Negative Result: Suggests absence of tested NCF1 mutations, though additional genetic testing may be recommended based on clinical presentation
  • Variant of Uncertain Significance: Requires further evaluation and possibly family member testing for clarification
  • Carrier Status: Identifies individuals with one mutated copy who may pass the condition to offspring

Test Details and Pricing

Test Component Details
Test Name NCF1 Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome B Positive Type 1 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified genetic counselors and medical professionals ensures accessible, high-quality genetic testing services nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about genetic conditions affect your health decisions. Our comprehensive NCF1 Gene Granulomatous Disease DNA Test provides the clarity you need for informed medical planning. With our discounted price of $500 USD and rapid 3-4 week turnaround, you can access cutting-edge genetic diagnostics without delay.

Call or WhatsApp our genetic specialists today at +1(267) 388-9828 to schedule your consultation and testing appointment. Early detection through genetic testing can significantly improve treatment outcomes and quality of life for individuals with chronic granulomatous disease.